N/A
N=12
Diabetes Homelessness Medication Support Program in Spanish
Diabetes Mellitus, Type 2
Bottom Line
View on ClinicalTrials.gov: NCT05819749 ↗Enrolled (actual)
12
Serious AEs
0.0%
Results posted
Oct 2024
Primary outcome: Primary: Acceptability of Intervention — 30.5 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Diabetes Homelessness Medication Support Program in Spanish (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Hennepin Healthcare Research Institute
- Primary completion
- Feb 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Acceptability of Intervention |
30.5 | — |
| SECONDARY Change in Glycemic Control |
9.1; 8.2 | — |
| SECONDARY Health-related Quality of Life |
41.2; 39.7; 46.4; 49.7 | — |
| SECONDARY Diabetes Medication Adherence |
14.6; 14.2 | — |
Summary
This single-arm trial of the Diabetes Homeless Medication Support intervention for Spanish-speaking people (n=12) will test the perception and feasibility of anticipated study procedures.
Eligibility Criteria
Inclusion Criteria
- Age 18 yrs or older
- Spanish-speaking
- Recent homelessness by federal definition (HEARTH ACT)
- Any housing instability in the last 12 mo. (includes supported housing or worry about paying rent)
- Significant housing instability in the last 24 mos. (includes any stay in shelter, outside, or places not meant for human habitation)
- Self-reported diagnosis of type 2 diabetes, later verified in medical record
- Plan to stay in local area or be reachable by phone for the next 16 weeks
- Willingness to work on medication adherence and diabetes self-care
Exclusion Criteria
- Inability to provide informed consent (e.g. presence of a legal guardian, prisoners)
- Active psychosis or intoxication precluding ability to give informed consent
- Pregnant or lactating females
- Patients who choose to opt out of research
Data sourced from ClinicalTrials.gov (NCT05819749). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.